发明名称 |
ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE |
摘要 |
Compositions and methods of therapy for treating diseases mediated by stimulation of CD40 signaling on CD40-expressing cells are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity, but exhibits antagonist activity when the antibody binds a CD40 antigen on a human CD40-expressing cell. Antagonist activity of the anti-CD40 antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of human CD40-expressing cells, such as B cells. |
申请公布号 |
US2008254026(A1) |
申请公布日期 |
2008.10.16 |
申请号 |
US20070932472 |
申请日期 |
2007.10.31 |
申请人 |
NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
发明人 |
LONG LI;LUQMAN MOHAMMAD;YABANNAVAR ASHA;ZAROR ISABEL;CHEN BAO-LU;LU XIAOFENG;LEE SANG HOON;HURST DEBORAH;AUKERMAN SHARON LEA;LOPES DE MENEZES DANIEL E. |
分类号 |
A61K39/395;A61P1/00;A61P37/00;C07H21/00;C07K16/18;C12N5/06;G01N33/574 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|